glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche is 'on par' with
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche is 'on par' with](https://www.mmm-online.com/wp-content/uploads/sites/2/2023/09/GettyImages-137641890-860x574.jpg)
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche is 'on par' with](https://cphoto.asiae.co.kr/listimglink/1/2026012819584919755_1769597929.png)
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche is 'on par' with](https://static.biospace.com/dims4/default/7c8a734/2147483647/strip/false/crop/3803x2139+0+239/resize/1200x675!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F68%2Fb4%2Ff13d76df42619d636b92913eb589%2Fistock-804989330.jpg)
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche is 'on par' with](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1812040254%20%281%29.jpg?VersionId=idd_CDc5t_JQ44nQ1BNBX6PQ__RT5x2Q)


















